More Business Wire
View Older Stories View Newer Stories-
Crestone Announces Positive Data from Phase 2 Clinical Trial of CRS3123 for C. difficile Infections Published in The Lancet Infectious Diseases
-
United Educators Appoints Bryan Elie as Vice President for Strategic Market Engagement
-
HilltopSecurities Donates $80,000 to Texas Schools with Hilltop Hunt Program
-
Nebius Names Dan Lawrence to Lead Expansion in the US as Senior Vice President and General Manager for the Americas
-
LogProstyle Announces Commencement of Previously Announced $543,455 Share Repurchase Program
-
Arch Painting® Announces White Glove Guarantee for Commercial Customers
-
Security Validation | SecValMSSP and Stellar Cyber Partner to Deliver Outcome-Driven Managed Security Services
-
Mobix Labs Advances AI Drone Intelligence Platform for Defense and Infrastructure Applications
-
American Express Global Business Travel Reports Strong Fourth Quarter and Full-Year 2025 Financial Results
-
NUBURU Enters the $20B Global Counter-Drone Defense Market as Lyocon Completes Proof-of-Concept for Portable Directed-Energy Laser Platform
-
AeriTek Acquires Federal Industries, Significantly Bolstering U.S. Presence
-
Amazon Pharmacy Expands Access to Eli Lilly’s Zepbound KwikPen for Weight Management
-
Nearly All Valvoline Instant Oil Change Service Centers Named a CARFAX 2025 Top-Rated Service Center
-
Cannae Holdings, Inc. Announces Increase in Share Repurchase Authorization, Expanding its Commitment to Returning Capital to Shareholders
-
Primaris REIT Renews Normal Course Issuer Bid
-
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
-
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
-
Data Management Overtakes Cost and Talent as Top AI Challenge as 65% of Enterprises Race to Build Reliable Agentic Capabilities
-
TASKING Accelerates the Development and Verification of Safety- and Security-Critical AUTOSAR Compliant Systems
-
Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event
-
ACCO Brands Reports Fourth Quarter and Full Year Results and Provides Outlook for 2026
-
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
-
Gulfport Energy Announces Leadership Team Changes
-
Horizon Quantum Announces Expected New Board Members and Chief Legal Officer
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
-
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
-
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
-
QXO Launches Sixth Annual Campaign to Celebrate Women in Roofing
-
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer
-
ILS (Intelligent Legal Solutions) Raises $3M in Funding Led by Chicago Ventures
-
Kinaxis Announces Amendment to Maximize Size of Normal Course Issuer Bid
-
AN2 Therapeutics Announces $40 Million Private Placement Financing
-
Zilliant Survey: 45% of Execs Cite Tariffs as Top Pricing Threat as Food Manufacturing Volatility Becomes Structural
-
KNAPP North America Establishes Executive-Led Customer Service Model for Large-Scale Automation
-
Ionis announces changes to Board of Directors
-
Starboard Delivers Letter to Lamb Weston
-
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
-
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
-
Fluor Announces Appointment of Robert G. (Bob) Card to its Board of Directors
-
Fluor Announces Retirement of Executive Chairman, David E. Constable, and Appointment of James T. (Jim) Hackett as Chairman of the Board
-
Oklo, Centrus Announce Planned Joint Venture to Advance Nuclear Fuel Services in Ohio
-
Korn Ferry Announces Third Quarter Fiscal 2026 Results of Operations
-
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
-
Jefferies Discloses Facts About Western Alliance and Western Alliance’s Loan Solely Against First Brands Receivables
-
Chemtrade Logistics Income Fund Announces Filing of Audited Financial Statements for 2025
-
Dealings in Securities by Executive Directors of AngloGold Ashanti plc
-
Citi Issues Inaugural Digitally Native Structured Note on Euroclear's D-FMI DLT Platform
-
Dispersive® Stealth Networking Powers Secure GPU-as-a-Service at the Edge as AI Demand Outpaces Infrastructure
-
KRISPY KREME® is Bringing Guests ‘All the Luck’ this St. Patrick’s Day with Fun Doughnuts, Sweeter Deals and a Chance to Win Free Doughnuts for a Year
-
Marti Launches Shareholder Loyalty Program
